Table of Content

1 Study Coverage
1.1 Leukotriene Inhibitors Product Introduction
1.2 Market by Type
1.2.1 Global Leukotriene Inhibitors Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Montelukast
1.2.3 Zafirlukast
1.2.4 Proust
1.2.5 Other
1.3 Market by Application
1.3.1 Global Leukotriene Inhibitors Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Asthma
1.3.3 COPD
1.3.4 Allergic Rhinitis
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Leukotriene Inhibitors Sales Estimates and Forecasts 2018-2029
2.2 Global Leukotriene Inhibitors Revenue by Region
2.2.1 Global Leukotriene Inhibitors Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Leukotriene Inhibitors Revenue by Region (2018-2024)
2.2.3 Global Leukotriene Inhibitors Revenue by Region (2024-2029)
2.2.4 Global Leukotriene Inhibitors Revenue Market Share by Region (2018-2029)
2.3 Global Leukotriene Inhibitors Sales Estimates and Forecasts 2018-2029
2.4 Global Leukotriene Inhibitors Sales by Region
2.4.1 Global Leukotriene Inhibitors Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Leukotriene Inhibitors Sales by Region (2018-2024)
2.4.3 Global Leukotriene Inhibitors Sales by Region (2024-2029)
2.4.4 Global Leukotriene Inhibitors Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Leukotriene Inhibitors Sales by Manufacturers
3.1.1 Global Leukotriene Inhibitors Sales by Manufacturers (2018-2024)
3.1.2 Global Leukotriene Inhibitors Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Leukotriene Inhibitors in 2022
3.2 Global Leukotriene Inhibitors Revenue by Manufacturers
3.2.1 Global Leukotriene Inhibitors Revenue by Manufacturers (2018-2024)
3.2.2 Global Leukotriene Inhibitors Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Leukotriene Inhibitors Revenue in 2022
3.3 Global Key Players of Leukotriene Inhibitors, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Leukotriene Inhibitors Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Leukotriene Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Leukotriene Inhibitors, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Leukotriene Inhibitors, Product Offered and Application
3.8 Global Key Manufacturers of Leukotriene Inhibitors, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Leukotriene Inhibitors Sales by Type
4.1.1 Global Leukotriene Inhibitors Historical Sales by Type (2018-2024)
4.1.2 Global Leukotriene Inhibitors Forecasted Sales by Type (2024-2029)
4.1.3 Global Leukotriene Inhibitors Sales Market Share by Type (2018-2029)
4.2 Global Leukotriene Inhibitors Revenue by Type
4.2.1 Global Leukotriene Inhibitors Historical Revenue by Type (2018-2024)
4.2.2 Global Leukotriene Inhibitors Forecasted Revenue by Type (2024-2029)
4.2.3 Global Leukotriene Inhibitors Revenue Market Share by Type (2018-2029)
4.3 Global Leukotriene Inhibitors Price by Type
4.3.1 Global Leukotriene Inhibitors Price by Type (2018-2024)
4.3.2 Global Leukotriene Inhibitors Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Leukotriene Inhibitors Sales by Application
5.1.1 Global Leukotriene Inhibitors Historical Sales by Application (2018-2024)
5.1.2 Global Leukotriene Inhibitors Forecasted Sales by Application (2024-2029)
5.1.3 Global Leukotriene Inhibitors Sales Market Share by Application (2018-2029)
5.2 Global Leukotriene Inhibitors Revenue by Application
5.2.1 Global Leukotriene Inhibitors Historical Revenue by Application (2018-2024)
5.2.2 Global Leukotriene Inhibitors Forecasted Revenue by Application (2024-2029)
5.2.3 Global Leukotriene Inhibitors Revenue Market Share by Application (2018-2029)
5.3 Global Leukotriene Inhibitors Price by Application
5.3.1 Global Leukotriene Inhibitors Price by Application (2018-2024)
5.3.2 Global Leukotriene Inhibitors Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Leukotriene Inhibitors Market Size by Type
6.1.1 US & Canada Leukotriene Inhibitors Sales by Type (2018-2029)
6.1.2 US & Canada Leukotriene Inhibitors Revenue by Type (2018-2029)
6.2 US & Canada Leukotriene Inhibitors Market Size by Application
6.2.1 US & Canada Leukotriene Inhibitors Sales by Application (2018-2029)
6.2.2 US & Canada Leukotriene Inhibitors Revenue by Application (2018-2029)
6.3 US & Canada Leukotriene Inhibitors Market Size by Country
6.3.1 US & Canada Leukotriene Inhibitors Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Leukotriene Inhibitors Sales by Country (2018-2029)
6.3.3 US & Canada Leukotriene Inhibitors Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Leukotriene Inhibitors Market Size by Type
7.1.1 Europe Leukotriene Inhibitors Sales by Type (2018-2029)
7.1.2 Europe Leukotriene Inhibitors Revenue by Type (2018-2029)
7.2 Europe Leukotriene Inhibitors Market Size by Application
7.2.1 Europe Leukotriene Inhibitors Sales by Application (2018-2029)
7.2.2 Europe Leukotriene Inhibitors Revenue by Application (2018-2029)
7.3 Europe Leukotriene Inhibitors Market Size by Country
7.3.1 Europe Leukotriene Inhibitors Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Leukotriene Inhibitors Sales by Country (2018-2029)
7.3.3 Europe Leukotriene Inhibitors Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Leukotriene Inhibitors Market Size
8.1.1 China Leukotriene Inhibitors Sales (2018-2029)
8.1.2 China Leukotriene Inhibitors Revenue (2018-2029)
8.2 China Leukotriene Inhibitors Market Size by Application
8.2.1 China Leukotriene Inhibitors Sales by Application (2018-2029)
8.2.2 China Leukotriene Inhibitors Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Leukotriene Inhibitors Market Size by Type
9.1.1 Asia Leukotriene Inhibitors Sales by Type (2018-2029)
9.1.2 Asia Leukotriene Inhibitors Revenue by Type (2018-2029)
9.2 Asia Leukotriene Inhibitors Market Size by Application
9.2.1 Asia Leukotriene Inhibitors Sales by Application (2018-2029)
9.2.2 Asia Leukotriene Inhibitors Revenue by Application (2018-2029)
9.3 Asia Leukotriene Inhibitors Sales by Region
9.3.1 Asia Leukotriene Inhibitors Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Leukotriene Inhibitors Revenue by Region (2018-2029)
9.3.3 Asia Leukotriene Inhibitors Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Leukotriene Inhibitors Market Size by Type
10.1.1 Middle East, Africa and Latin America Leukotriene Inhibitors Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Leukotriene Inhibitors Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Leukotriene Inhibitors Market Size by Application
10.2.1 Middle East, Africa and Latin America Leukotriene Inhibitors Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Leukotriene Inhibitors Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Leukotriene Inhibitors Sales by Country
10.3.1 Middle East, Africa and Latin America Leukotriene Inhibitors Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Leukotriene Inhibitors Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Leukotriene Inhibitors Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Mallinckrodt plc
11.1.1 Mallinckrodt plc Company Information
11.1.2 Mallinckrodt plc Overview
11.1.3 Mallinckrodt plc Leukotriene Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Mallinckrodt plc Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Mallinckrodt plc Recent Developments
11.2 Sun Pharmaceutical Industries Ltd
11.2.1 Sun Pharmaceutical Industries Ltd Company Information
11.2.2 Sun Pharmaceutical Industries Ltd Overview
11.2.3 Sun Pharmaceutical Industries Ltd Leukotriene Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Sun Pharmaceutical Industries Ltd Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sun Pharmaceutical Industries Ltd Recent Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Information
11.3.2 Novartis AG Overview
11.3.3 Novartis AG Leukotriene Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Novartis AG Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis AG Recent Developments
11.4 Endo Pharmaceuticals plc
11.4.1 Endo Pharmaceuticals plc Company Information
11.4.2 Endo Pharmaceuticals plc Overview
11.4.3 Endo Pharmaceuticals plc Leukotriene Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Endo Pharmaceuticals plc Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Endo Pharmaceuticals plc Recent Developments
11.5 Zydus Cadila
11.5.1 Zydus Cadila Company Information
11.5.2 Zydus Cadila Overview
11.5.3 Zydus Cadila Leukotriene Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Zydus Cadila Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Zydus Cadila Recent Developments
11.6 Mylan NV
11.6.1 Mylan NV Company Information
11.6.2 Mylan NV Overview
11.6.3 Mylan NV Leukotriene Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Mylan NV Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Mylan NV Recent Developments
11.7 Mayne Pharma Group Limited
11.7.1 Mayne Pharma Group Limited Company Information
11.7.2 Mayne Pharma Group Limited Overview
11.7.3 Mayne Pharma Group Limited Leukotriene Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Mayne Pharma Group Limited Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Mayne Pharma Group Limited Recent Developments
11.8 Teva Pharmaceutical Industries Ltd
11.8.1 Teva Pharmaceutical Industries Ltd Company Information
11.8.2 Teva Pharmaceutical Industries Ltd Overview
11.8.3 Teva Pharmaceutical Industries Ltd Leukotriene Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Teva Pharmaceutical Industries Ltd Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Teva Pharmaceutical Industries Ltd Recent Developments
11.9 Amneal Pharmaceutical Inc
11.9.1 Amneal Pharmaceutical Inc Company Information
11.9.2 Amneal Pharmaceutical Inc Overview
11.9.3 Amneal Pharmaceutical Inc Leukotriene Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Amneal Pharmaceutical Inc Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Amneal Pharmaceutical Inc Recent Developments
11.10 Avet Pharmaceuticals Inc
11.10.1 Avet Pharmaceuticals Inc Company Information
11.10.2 Avet Pharmaceuticals Inc Overview
11.10.3 Avet Pharmaceuticals Inc Leukotriene Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Avet Pharmaceuticals Inc Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Avet Pharmaceuticals Inc Recent Developments
11.11 Aurobindo Pharma
11.11.1 Aurobindo Pharma Company Information
11.11.2 Aurobindo Pharma Overview
11.11.3 Aurobindo Pharma Leukotriene Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Aurobindo Pharma Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Aurobindo Pharma Recent Developments
11.12 GSK plc
11.12.1 GSK plc Company Information
11.12.2 GSK plc Overview
11.12.3 GSK plc Leukotriene Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 GSK plc Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 GSK plc Recent Developments
11.13 Almirall, SA
11.13.1 Almirall, SA Company Information
11.13.2 Almirall, SA Overview
11.13.3 Almirall, SA Leukotriene Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Almirall, SA Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Almirall, SA Recent Developments
11.14 Merck & Co., Inc
11.14.1 Merck & Co., Inc Company Information
11.14.2 Merck & Co., Inc Overview
11.14.3 Merck & Co., Inc Leukotriene Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Merck & Co., Inc Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Merck & Co., Inc Recent Developments
11.15 Bausch Health
11.15.1 Bausch Health Company Information
11.15.2 Bausch Health Overview
11.15.3 Bausch Health Leukotriene Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Bausch Health Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Bausch Health Recent Developments
11.16 Sandoz International GmbH
11.16.1 Sandoz International GmbH Company Information
11.16.2 Sandoz International GmbH Overview
11.16.3 Sandoz International GmbH Leukotriene Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Sandoz International GmbH Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Sandoz International GmbH Recent Developments
11.17 Circassia Pharmaceuticals
11.17.1 Circassia Pharmaceuticals Company Information
11.17.2 Circassia Pharmaceuticals Overview
11.17.3 Circassia Pharmaceuticals Leukotriene Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Circassia Pharmaceuticals Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Circassia Pharmaceuticals Recent Developments
11.18 AstraZeneca
11.18.1 AstraZeneca Company Information
11.18.2 AstraZeneca Overview
11.18.3 AstraZeneca Leukotriene Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 AstraZeneca Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 AstraZeneca Recent Developments
11.19 Sanofi
11.19.1 Sanofi Company Information
11.19.2 Sanofi Overview
11.19.3 Sanofi Leukotriene Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.19.4 Sanofi Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Sanofi Recent Developments
11.20 McKesson Corporation
11.20.1 McKesson Corporation Company Information
11.20.2 McKesson Corporation Overview
11.20.3 McKesson Corporation Leukotriene Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.20.4 McKesson Corporation Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 McKesson Corporation Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Leukotriene Inhibitors Industry Chain Analysis
12.2 Leukotriene Inhibitors Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Leukotriene Inhibitors Production Mode & Process
12.4 Leukotriene Inhibitors Sales and Marketing
12.4.1 Leukotriene Inhibitors Sales Channels
12.4.2 Leukotriene Inhibitors Distributors
12.5 Leukotriene Inhibitors Customers
13 Market Dynamics
13.1 Leukotriene Inhibitors Industry Trends
13.2 Leukotriene Inhibitors Market Drivers
13.3 Leukotriene Inhibitors Market Challenges
13.4 Leukotriene Inhibitors Market Restraints
14 Key Findings in The Global Leukotriene Inhibitors Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Leukotriene Inhibitors Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Montelukast
Table 3. Major Manufacturers of Zafirlukast
Table 4. Major Manufacturers of Proust
Table 5. Major Manufacturers of Other
Table 6. Global Leukotriene Inhibitors Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Leukotriene Inhibitors Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Leukotriene Inhibitors Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Leukotriene Inhibitors Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Leukotriene Inhibitors Revenue Market Share by Region (2018-2024)
Table 11. Global Leukotriene Inhibitors Revenue Market Share by Region (2024-2029)
Table 12. Global Leukotriene Inhibitors Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Leukotriene Inhibitors Sales by Region (2018-2024) & (K Units)
Table 14. Global Leukotriene Inhibitors Sales by Region (2024-2029) & (K Units)
Table 15. Global Leukotriene Inhibitors Sales Market Share by Region (2018-2024)
Table 16. Global Leukotriene Inhibitors Sales Market Share by Region (2024-2029)
Table 17. Global Leukotriene Inhibitors Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Leukotriene Inhibitors Sales Share by Manufacturers (2018-2024)
Table 19. Global Leukotriene Inhibitors Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Leukotriene Inhibitors Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Leukotriene Inhibitors, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Leukotriene Inhibitors Price by Manufacturers 2018-2024 (US$/Unit)
Table 23. Global Leukotriene Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Leukotriene Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukotriene Inhibitors as of 2022)
Table 25. Global Key Manufacturers of Leukotriene Inhibitors, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Leukotriene Inhibitors, Product Offered and Application
Table 27. Global Key Manufacturers of Leukotriene Inhibitors, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Leukotriene Inhibitors Sales by Type (2018-2024) & (K Units)
Table 30. Global Leukotriene Inhibitors Sales by Type (2024-2029) & (K Units)
Table 31. Global Leukotriene Inhibitors Sales Share by Type (2018-2024)
Table 32. Global Leukotriene Inhibitors Sales Share by Type (2024-2029)
Table 33. Global Leukotriene Inhibitors Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Leukotriene Inhibitors Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Leukotriene Inhibitors Revenue Share by Type (2018-2024)
Table 36. Global Leukotriene Inhibitors Revenue Share by Type (2024-2029)
Table 37. Leukotriene Inhibitors Price by Type (2018-2024) & (US$/Unit)
Table 38. Global Leukotriene Inhibitors Price Forecast by Type (2024-2029) & (US$/Unit)
Table 39. Global Leukotriene Inhibitors Sales by Application (2018-2024) & (K Units)
Table 40. Global Leukotriene Inhibitors Sales by Application (2024-2029) & (K Units)
Table 41. Global Leukotriene Inhibitors Sales Share by Application (2018-2024)
Table 42. Global Leukotriene Inhibitors Sales Share by Application (2024-2029)
Table 43. Global Leukotriene Inhibitors Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Leukotriene Inhibitors Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Leukotriene Inhibitors Revenue Share by Application (2018-2024)
Table 46. Global Leukotriene Inhibitors Revenue Share by Application (2024-2029)
Table 47. Leukotriene Inhibitors Price by Application (2018-2024) & (US$/Unit)
Table 48. Global Leukotriene Inhibitors Price Forecast by Application (2024-2029) & (US$/Unit)
Table 49. US & Canada Leukotriene Inhibitors Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Leukotriene Inhibitors Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Leukotriene Inhibitors Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Leukotriene Inhibitors Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Leukotriene Inhibitors Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Leukotriene Inhibitors Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Leukotriene Inhibitors Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Leukotriene Inhibitors Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Leukotriene Inhibitors Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Leukotriene Inhibitors Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Leukotriene Inhibitors Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Leukotriene Inhibitors Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Leukotriene Inhibitors Sales by Country (2024-2029) & (K Units)
Table 62. Europe Leukotriene Inhibitors Sales by Type (2018-2024) & (K Units)
Table 63. Europe Leukotriene Inhibitors Sales by Type (2024-2029) & (K Units)
Table 64. Europe Leukotriene Inhibitors Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Leukotriene Inhibitors Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Leukotriene Inhibitors Sales by Application (2018-2024) & (K Units)
Table 67. Europe Leukotriene Inhibitors Sales by Application (2024-2029) & (K Units)
Table 68. Europe Leukotriene Inhibitors Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Leukotriene Inhibitors Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Leukotriene Inhibitors Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Leukotriene Inhibitors Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Leukotriene Inhibitors Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Leukotriene Inhibitors Sales by Country (2018-2024) & (K Units)
Table 74. Europe Leukotriene Inhibitors Sales by Country (2024-2029) & (K Units)
Table 75. China Leukotriene Inhibitors Sales by Type (2018-2024) & (K Units)
Table 76. China Leukotriene Inhibitors Sales by Type (2024-2029) & (K Units)
Table 77. China Leukotriene Inhibitors Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Leukotriene Inhibitors Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Leukotriene Inhibitors Sales by Application (2018-2024) & (K Units)
Table 80. China Leukotriene Inhibitors Sales by Application (2024-2029) & (K Units)
Table 81. China Leukotriene Inhibitors Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Leukotriene Inhibitors Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Leukotriene Inhibitors Sales by Type (2018-2024) & (K Units)
Table 84. Asia Leukotriene Inhibitors Sales by Type (2024-2029) & (K Units)
Table 85. Asia Leukotriene Inhibitors Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Leukotriene Inhibitors Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Leukotriene Inhibitors Sales by Application (2018-2024) & (K Units)
Table 88. Asia Leukotriene Inhibitors Sales by Application (2024-2029) & (K Units)
Table 89. Asia Leukotriene Inhibitors Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Leukotriene Inhibitors Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Leukotriene Inhibitors Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Leukotriene Inhibitors Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Leukotriene Inhibitors Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Leukotriene Inhibitors Sales by Region (2018-2024) & (K Units)
Table 95. Asia Leukotriene Inhibitors Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Leukotriene Inhibitors Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Leukotriene Inhibitors Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Leukotriene Inhibitors Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Leukotriene Inhibitors Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Leukotriene Inhibitors Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Leukotriene Inhibitors Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Leukotriene Inhibitors Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Leukotriene Inhibitors Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Leukotriene Inhibitors Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Leukotriene Inhibitors Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Leukotriene Inhibitors Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Leukotriene Inhibitors Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Leukotriene Inhibitors Sales by Country (2024-2029) & (K Units)
Table 109. Mallinckrodt plc Company Information
Table 110. Mallinckrodt plc Description and Major Businesses
Table 111. Mallinckrodt plc Leukotriene Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Mallinckrodt plc Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Mallinckrodt plc Recent Developments
Table 114. Sun Pharmaceutical Industries Ltd Company Information
Table 115. Sun Pharmaceutical Industries Ltd Description and Major Businesses
Table 116. Sun Pharmaceutical Industries Ltd Leukotriene Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Sun Pharmaceutical Industries Ltd Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Sun Pharmaceutical Industries Ltd Recent Developments
Table 119. Novartis AG Company Information
Table 120. Novartis AG Description and Major Businesses
Table 121. Novartis AG Leukotriene Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Novartis AG Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Novartis AG Recent Developments
Table 124. Endo Pharmaceuticals plc Company Information
Table 125. Endo Pharmaceuticals plc Description and Major Businesses
Table 126. Endo Pharmaceuticals plc Leukotriene Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Endo Pharmaceuticals plc Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Endo Pharmaceuticals plc Recent Developments
Table 129. Zydus Cadila Company Information
Table 130. Zydus Cadila Description and Major Businesses
Table 131. Zydus Cadila Leukotriene Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Zydus Cadila Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Zydus Cadila Recent Developments
Table 134. Mylan NV Company Information
Table 135. Mylan NV Description and Major Businesses
Table 136. Mylan NV Leukotriene Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Mylan NV Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Mylan NV Recent Developments
Table 139. Mayne Pharma Group Limited Company Information
Table 140. Mayne Pharma Group Limited Description and Major Businesses
Table 141. Mayne Pharma Group Limited Leukotriene Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Mayne Pharma Group Limited Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Mayne Pharma Group Limited Recent Developments
Table 144. Teva Pharmaceutical Industries Ltd Company Information
Table 145. Teva Pharmaceutical Industries Ltd Description and Major Businesses
Table 146. Teva Pharmaceutical Industries Ltd Leukotriene Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. Teva Pharmaceutical Industries Ltd Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Teva Pharmaceutical Industries Ltd Recent Developments
Table 149. Amneal Pharmaceutical Inc Company Information
Table 150. Amneal Pharmaceutical Inc Description and Major Businesses
Table 151. Amneal Pharmaceutical Inc Leukotriene Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Amneal Pharmaceutical Inc Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Amneal Pharmaceutical Inc Recent Developments
Table 154. Avet Pharmaceuticals Inc Company Information
Table 155. Avet Pharmaceuticals Inc Description and Major Businesses
Table 156. Avet Pharmaceuticals Inc Leukotriene Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Avet Pharmaceuticals Inc Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Avet Pharmaceuticals Inc Recent Developments
Table 159. Aurobindo Pharma Company Information
Table 160. Aurobindo Pharma Description and Major Businesses
Table 161. Aurobindo Pharma Leukotriene Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. Aurobindo Pharma Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Aurobindo Pharma Recent Developments
Table 164. GSK plc Company Information
Table 165. GSK plc Description and Major Businesses
Table 166. GSK plc Leukotriene Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. GSK plc Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. GSK plc Recent Developments
Table 169. Almirall, SA Company Information
Table 170. Almirall, SA Description and Major Businesses
Table 171. Almirall, SA Leukotriene Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 172. Almirall, SA Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. Almirall, SA Recent Developments
Table 174. Merck & Co., Inc Company Information
Table 175. Merck & Co., Inc Description and Major Businesses
Table 176. Merck & Co., Inc Leukotriene Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 177. Merck & Co., Inc Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 178. Merck & Co., Inc Recent Developments
Table 179. Bausch Health Company Information
Table 180. Bausch Health Description and Major Businesses
Table 181. Bausch Health Leukotriene Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 182. Bausch Health Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 183. Bausch Health Recent Developments
Table 184. Sandoz International GmbH Company Information
Table 185. Sandoz International GmbH Description and Major Businesses
Table 186. Sandoz International GmbH Leukotriene Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 187. Sandoz International GmbH Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 188. Sandoz International GmbH Recent Developments
Table 189. Circassia Pharmaceuticals Company Information
Table 190. Circassia Pharmaceuticals Description and Major Businesses
Table 191. Circassia Pharmaceuticals Leukotriene Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 192. Circassia Pharmaceuticals Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 193. Circassia Pharmaceuticals Recent Developments
Table 194. AstraZeneca Company Information
Table 195. AstraZeneca Description and Major Businesses
Table 196. AstraZeneca Leukotriene Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 197. AstraZeneca Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 198. AstraZeneca Recent Developments
Table 199. Sanofi Company Information
Table 200. Sanofi Description and Major Businesses
Table 201. Sanofi Leukotriene Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 202. Sanofi Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 203. Sanofi Recent Developments
Table 204. McKesson Corporation Company Information
Table 205. McKesson Corporation Description and Major Businesses
Table 206. McKesson Corporation Leukotriene Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 207. McKesson Corporation Leukotriene Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 208. McKesson Corporation Recent Developments
Table 209. Key Raw Materials Lists
Table 210. Raw Materials Key Suppliers Lists
Table 211. Leukotriene Inhibitors Distributors List
Table 212. Leukotriene Inhibitors Customers List
Table 213. Leukotriene Inhibitors Market Trends
Table 214. Leukotriene Inhibitors Market Drivers
Table 215. Leukotriene Inhibitors Market Challenges
Table 216. Leukotriene Inhibitors Market Restraints
Table 217. Research Programs/Design for This Report
Table 218. Key Data Information from Secondary Sources
Table 219. Key Data Information from Primary Sources
List of Figures
Figure 1. Leukotriene Inhibitors Product Picture
Figure 2. Global Leukotriene Inhibitors Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Leukotriene Inhibitors Market Share by Type in 2022 & 2029
Figure 4. Montelukast Product Picture
Figure 5. Zafirlukast Product Picture
Figure 6. Proust Product Picture
Figure 7. Other Product Picture
Figure 8. Global Leukotriene Inhibitors Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Leukotriene Inhibitors Market Share by Application in 2022 & 2029
Figure 10. Asthma
Figure 11. COPD
Figure 12. Allergic Rhinitis
Figure 13. Other
Figure 14. Leukotriene Inhibitors Report Years Considered
Figure 15. Global Leukotriene Inhibitors Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Leukotriene Inhibitors Revenue 2018-2029 (US$ Million)
Figure 17. Global Leukotriene Inhibitors Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 18. Global Leukotriene Inhibitors Revenue Market Share by Region (2018-2029)
Figure 19. Global Leukotriene Inhibitors Sales 2018-2029 ((K Units)
Figure 20. Global Leukotriene Inhibitors Sales Market Share by Region (2018-2029)
Figure 21. US & Canada Leukotriene Inhibitors Sales YoY (2018-2029) & (K Units)
Figure 22. US & Canada Leukotriene Inhibitors Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Europe Leukotriene Inhibitors Sales YoY (2018-2029) & (K Units)
Figure 24. Europe Leukotriene Inhibitors Revenue YoY (2018-2029) & (US$ Million)
Figure 25. China Leukotriene Inhibitors Sales YoY (2018-2029) & (K Units)
Figure 26. China Leukotriene Inhibitors Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Asia (excluding China) Leukotriene Inhibitors Sales YoY (2018-2029) & (K Units)
Figure 28. Asia (excluding China) Leukotriene Inhibitors Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Leukotriene Inhibitors Sales YoY (2018-2029) & (K Units)
Figure 30. Middle East, Africa and Latin America Leukotriene Inhibitors Revenue YoY (2018-2029) & (US$ Million)
Figure 31. The Leukotriene Inhibitors Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of Leukotriene Inhibitors in the World: Market Share by Leukotriene Inhibitors Revenue in 2022
Figure 33. Global Leukotriene Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Leukotriene Inhibitors Sales Market Share by Type (2018-2029)
Figure 35. Global Leukotriene Inhibitors Revenue Market Share by Type (2018-2029)
Figure 36. Global Leukotriene Inhibitors Sales Market Share by Application (2018-2029)
Figure 37. Global Leukotriene Inhibitors Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Leukotriene Inhibitors Sales Market Share by Type (2018-2029)
Figure 39. US & Canada Leukotriene Inhibitors Revenue Market Share by Type (2018-2029)
Figure 40. US & Canada Leukotriene Inhibitors Sales Market Share by Application (2018-2029)
Figure 41. US & Canada Leukotriene Inhibitors Revenue Market Share by Application (2018-2029)
Figure 42. US & Canada Leukotriene Inhibitors Revenue Share by Country (2018-2029)
Figure 43. US & Canada Leukotriene Inhibitors Sales Share by Country (2018-2029)
Figure 44. U.S. Leukotriene Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 45. Canada Leukotriene Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 46. Europe Leukotriene Inhibitors Sales Market Share by Type (2018-2029)
Figure 47. Europe Leukotriene Inhibitors Revenue Market Share by Type (2018-2029)
Figure 48. Europe Leukotriene Inhibitors Sales Market Share by Application (2018-2029)
Figure 49. Europe Leukotriene Inhibitors Revenue Market Share by Application (2018-2029)
Figure 50. Europe Leukotriene Inhibitors Revenue Share by Country (2018-2029)
Figure 51. Europe Leukotriene Inhibitors Sales Share by Country (2018-2029)
Figure 52. Germany Leukotriene Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 53. France Leukotriene Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 54. U.K. Leukotriene Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 55. Italy Leukotriene Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 56. Russia Leukotriene Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 57. China Leukotriene Inhibitors Sales Market Share by Type (2018-2029)
Figure 58. China Leukotriene Inhibitors Revenue Market Share by Type (2018-2029)
Figure 59. China Leukotriene Inhibitors Sales Market Share by Application (2018-2029)
Figure 60. China Leukotriene Inhibitors Revenue Market Share by Application (2018-2029)
Figure 61. Asia Leukotriene Inhibitors Sales Market Share by Type (2018-2029)
Figure 62. Asia Leukotriene Inhibitors Revenue Market Share by Type (2018-2029)
Figure 63. Asia Leukotriene Inhibitors Sales Market Share by Application (2018-2029)
Figure 64. Asia Leukotriene Inhibitors Revenue Market Share by Application (2018-2029)
Figure 65. Asia Leukotriene Inhibitors Revenue Share by Region (2018-2029)
Figure 66. Asia Leukotriene Inhibitors Sales Share by Region (2018-2029)
Figure 67. Japan Leukotriene Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 68. South Korea Leukotriene Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 69. China Taiwan Leukotriene Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 70. Southeast Asia Leukotriene Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 71. India Leukotriene Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 72. Middle East, Africa and Latin America Leukotriene Inhibitors Sales Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Leukotriene Inhibitors Revenue Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America Leukotriene Inhibitors Sales Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Leukotriene Inhibitors Revenue Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Leukotriene Inhibitors Revenue Share by Country (2018-2029)
Figure 77. Middle East, Africa and Latin America Leukotriene Inhibitors Sales Share by Country (2018-2029)
Figure 78. Brazil Leukotriene Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 79. Mexico Leukotriene Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 80. Turkey Leukotriene Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 81. Israel Leukotriene Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 82. GCC Countries Leukotriene Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 83. Leukotriene Inhibitors Value Chain
Figure 84. Leukotriene Inhibitors Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed